Virtus ETF Advisers’s Zimmer Biomet ZBH Stock Holding History

Virtus ETF Advisers’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-160	Closed	-$17K	–	370
2018 Q2	$17K	Hold	160	–	–	0.02%	228
2018 Q1	$17K	Buy	+160	New	+$18.6K	0.01%	206

Other funds holding ZBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Virtus ETF Advisers's ZBH Position: Q3 2018 in Review

Virtus ETF Advisers sold out of Zimmer Biomet (ZBH) in Q3 2018, closing a stake of 160 shares — an estimated $17K sold.

Virtus ETF Advisers first reported a position in ZBH in Q1 2018 and held it in 2 quarters. The position peaked at $17K in Q2 2018. 891 funds tracked by Wall St. Rank hold ZBH as of Q3 2018.

Virtus ETF Advisers reported no remaining Zimmer Biomet position as of Q3 2018 after selling out during the quarter.
Virtus ETF Advisers sold 160 Zimmer Biomet shares in Q3 2018, an estimated $17K.
Virtus ETF Advisers first reported a position in Zimmer Biomet in Q1 2018 and held it in 2 quarters.
Virtus ETF Advisers's Zimmer Biomet position peaked at $17K in Q2 2018.
891 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2018.

Based on Virtus ETF Advisers's 13F filing for Q3 2018, filed 14 Nov 2018.